HomeBUSINESS
BUSINESS

Kyorin Poised to Weather Kipres Cliff with Consecutive Drug Launches: President
(May.15.2017)

Kyorin Holdings President Minoru Hogawa
Kyorin Holdings is set to bring out an array of new drugs to the market in the coming years to make up for decreasing sales of Kipres (montelukast), a major treatment for bronchial asthma and allergic rhinitis that faced generic debuts in FY2016, President Minoru Hogawa stressed ...
(LOG IN FOR FULL STORY)

News Calendar